JP2012532868A5 - - Google Patents

Download PDF

Info

Publication number
JP2012532868A5
JP2012532868A5 JP2012519544A JP2012519544A JP2012532868A5 JP 2012532868 A5 JP2012532868 A5 JP 2012532868A5 JP 2012519544 A JP2012519544 A JP 2012519544A JP 2012519544 A JP2012519544 A JP 2012519544A JP 2012532868 A5 JP2012532868 A5 JP 2012532868A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
aryl
compound
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012519544A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532868A (ja
JP5676600B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/001926 external-priority patent/WO2011005322A2/en
Publication of JP2012532868A publication Critical patent/JP2012532868A/ja
Publication of JP2012532868A5 publication Critical patent/JP2012532868A5/ja
Application granted granted Critical
Publication of JP5676600B2 publication Critical patent/JP5676600B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012519544A 2009-07-08 2010-07-08 造影剤としてのn−アルコキシアミド抱合体 Expired - Fee Related JP5676600B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22394609P 2009-07-08 2009-07-08
US61/223,946 2009-07-08
PCT/US2010/001926 WO2011005322A2 (en) 2009-07-08 2010-07-08 N-alkoxyamide conjugates as imaging agents

Publications (3)

Publication Number Publication Date
JP2012532868A JP2012532868A (ja) 2012-12-20
JP2012532868A5 true JP2012532868A5 (https=) 2013-08-29
JP5676600B2 JP5676600B2 (ja) 2015-02-25

Family

ID=43429724

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012519544A Expired - Fee Related JP5676600B2 (ja) 2009-07-08 2010-07-08 造影剤としてのn−アルコキシアミド抱合体

Country Status (7)

Country Link
US (2) US8877157B2 (https=)
EP (1) EP2451776B1 (https=)
JP (1) JP5676600B2 (https=)
CN (1) CN102781909B (https=)
AU (1) AU2010271097B2 (https=)
CA (1) CA2803520C (https=)
WO (1) WO2011005322A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2405655T3 (es) 2006-12-26 2013-05-31 Lantheus Medical Imaging, Inc. N-[3-bromo-4-(3-[18F]fluoropropoxi)-bencil]-guanidina para la formación de imágenes de la inervación cardíaca
JP5730581B2 (ja) 2008-01-08 2015-06-10 ランセウス メディカル イメージング, インコーポレイテッド 造影剤としてのn−アルコキシアミド抱合体
WO2011005322A2 (en) 2009-07-08 2011-01-13 Lantheus Medical Imaging, Inc. N-alkoxyamide conjugates as imaging agents
ES2763815T3 (es) 2010-05-11 2020-06-01 Lantheus Medical Imaging Inc Composiciones, métodos y sistemas para la síntesis y uso de agentes de formación de imágenes
GB201102189D0 (en) * 2011-02-08 2011-03-23 King S College London Materials and methods relating to cardiovascular imaging
CN108484449A (zh) * 2011-09-09 2018-09-04 蓝瑟斯医学影像公司 用于合成和使用显像剂的组合物、方法和系统
WO2013070471A1 (en) 2011-11-11 2013-05-16 Lantheus Medical Imaging, Inc. Evaluation of presence of and vulnerability to atrial fibrillation and other indications using matrix metalloproteinase-based imaging
AU2013203000B9 (en) 2012-08-10 2017-02-02 Lantheus Medical Imaging, Inc. Compositions, methods, and systems for the synthesis and use of imaging agents
TWI780082B (zh) 2016-11-18 2022-10-11 日商安斯泰來製藥股份有限公司 新穎抗人類MUC1抗體Fab片段
TWI795415B (zh) 2017-07-07 2023-03-11 日商安斯泰來製藥股份有限公司 新穎的抗人類CEACAM5抗體Fab片段
BR112020023420A8 (pt) 2018-05-17 2022-07-05 Astellas Pharma Inc Complexo tendo fragmento fab de anticorpo anti-muc1 humano, peptídeo ligador e/ou ligante
SG11202103670XA (en) 2018-10-10 2021-05-28 Astellas Pharma Inc Pharmaceutical composition containing tagged site-antihuman antibody fab fragment complex
MX2021008230A (es) * 2019-01-07 2021-08-11 Astellas Pharma Inc Conjugado que comprende ligando y fragmento fab de anticuerpo ceacam5.
CN117486698B (zh) * 2023-10-30 2025-08-19 国网安徽省电力有限公司电力科学研究院 烯醇硅醚类化合物制备c-c键偶联产物的方法与sf6的应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5122885A (en) 1974-08-13 1976-02-23 Sagami Chem Res Ashiru ll aminosan oo chikanhidorokisamidono seizohoho
JPS5910322B2 (ja) * 1975-07-30 1984-03-08 三井東圧化学株式会社 殺草剤
US4859777A (en) 1981-07-01 1989-08-22 Eastman Kodak Company Terpyridine chelating agents
US4957939A (en) 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
AU6621586A (en) 1985-11-18 1987-06-02 University Of Texas System, The Polychelating agents for image and spectral enhancement (and spectral shift)
EP0233607B1 (en) 1986-02-18 1991-03-13 E.R. Squibb & Sons, Inc. [(2,2,2-Trichloroethoxy) methoxy]amine
US5064956A (en) 1987-06-24 1991-11-12 The Dow Chemical Company Process for preparing mono-n-alkylated polyazamacrocycles
IT1224627B (it) 1988-04-12 1990-10-04 Guidotti & C Spa Labor Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.
US5087440A (en) 1989-07-31 1992-02-11 Salutar, Inc. Heterocyclic derivatives of DTPA used for magnetic resonance imaging
US5089043A (en) 1989-11-09 1992-02-18 Shionogi & Co., Ltd. Heterocyclic oxy-phenoxyacetic acid derivatives and their use as herbicides
JPH0491070A (ja) 1990-08-06 1992-03-24 Kanebo Ltd カリックスアレーン誘導体
US5274129A (en) 1991-06-12 1993-12-28 Idaho Research Foundation, Inc. Hydroxamic acid crown ethers
GB9115375D0 (en) 1991-07-17 1991-09-04 Salutar Inc Compounds
US5639746A (en) 1994-12-29 1997-06-17 The Procter & Gamble Company Hydroxamic acid-containing inhibitors of matrix metalloproteases
TW319763B (https=) 1995-02-01 1997-11-11 Epix Medical Inc
JP3356289B2 (ja) * 1995-06-26 2002-12-16 コンキャット リミティド 第一遷移系列元素に対してキレート化親和性および選択性のある化合物とその医療および診断への使用
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
US6461587B1 (en) 1999-03-22 2002-10-08 Schering Aktiengesellschaft Perfluoroalkylamides, their production and their use in diagnosis
US6989139B2 (en) 2000-02-15 2006-01-24 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
US6656448B1 (en) * 2000-02-15 2003-12-02 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
US20020002152A1 (en) 2000-04-14 2002-01-03 Craig Richard A. Hydrazide and alkoxyamide angiogenesis inhibitors
AU2002254000A1 (en) 2001-02-23 2002-09-12 Bristol-Myers Squibb Pharma Company Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque
JP4590157B2 (ja) 2001-03-21 2010-12-01 アイシス イノヴェイション リミテッド アッセイ、方法および手段
TWI240632B (en) 2001-07-30 2005-10-01 Epix Medical Inc Purified peptides for peptide-based multimeric targeted contrast agents
WO2005001415A2 (en) * 2003-05-23 2005-01-06 Epix Pharmaceuticals, Inc. Optically pure and enriched isomers of chelating ligands and contrast agents
US7662856B2 (en) 2003-08-29 2010-02-16 The University Of Houston System Compositions having antimycrobial activity including a hydroxamate or a hydroxamate and a hydroxlyamine
US20050106100A1 (en) 2003-09-03 2005-05-19 Harris Thomas D. Compounds containing matrix metalloproteinase substrates and methods of their use
WO2005084179A2 (en) * 2003-12-01 2005-09-15 Immunomedics, Inc. Improved method for preparing conjugates of proteins and chelating agents
US20070142417A1 (en) 2005-05-11 2007-06-21 Aventis Pharmaceuticals Inc Substantially Pure 2-{[2-(2-Methylamino-Pyrimidin-4-YL)-1H-Indole-5-Carbonyl]-Amino}-3-Phenylpyridin-2-YL-Amino)-Propionic Acid as an IkB Kinase Inhibitor
WO2007005491A1 (en) 2005-06-30 2007-01-11 Bristol-Myers Squibb Pharma Company Hydrazide conjugates as imaging agents
US7618957B2 (en) * 2005-07-15 2009-11-17 Bayer Schering Pharma Aktiengesellschaft Perfluoroalkyl-containing complexes, process for their production as well as their use
JP5730581B2 (ja) 2008-01-08 2015-06-10 ランセウス メディカル イメージング, インコーポレイテッド 造影剤としてのn−アルコキシアミド抱合体
WO2011005322A2 (en) 2009-07-08 2011-01-13 Lantheus Medical Imaging, Inc. N-alkoxyamide conjugates as imaging agents

Similar Documents

Publication Publication Date Title
JP2012532868A5 (https=)
US8623322B2 (en) Non-invasive diagnostic agents and methods of diagnosing infectious disease
US8435489B2 (en) Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
RU2019142507A (ru) Композиции, способы и системы для синтеза и применение визуализирующих средств
JP2010526089A5 (https=)
RU2006133898A (ru) Производные бензимидазола и его применение
JP2011006480A5 (https=)
RU2018123484A (ru) Биарильные монобактамные соединения и способы их применения для лечения бактериальных инфекций
JP2013513613A5 (https=)
WO2009155017A3 (en) Novel substituted azabenzoxazoles
RU2017116176A (ru) Конъюгированные бисфосфонаты для диагностики и терапии заболеваний костей
RU2018134948A (ru) Бициклические арильные монобактамовые соединения и способы их применения для лечения бактериальных инфекций
KR20180081558A (ko) 장기간-지속되는 가돌리늄 기반 종양 표적화 이미징 및 치료 제제
JP2016521275A5 (https=)
RU2007108762A (ru) Диагностические соединения
BR112015026473B1 (pt) composições farmacêuticas líquidas e processo de preparação das mesmas e meio de contraste para imagiologia médica
RU2018118808A (ru) Сульфатные соли как ускорители времени прохода
JP2011509294A5 (https=)
Zhang et al. Synthesis and biological evaluation of a novel 99mTc (CO) 3 complex of ciprofloxacin dithiocarbamate as a potential agent to target infection
Haid et al. Lower radiation burden in state of the art fluoroscopic cystography compared to direct isotope cystography in children
JPH04154729A (ja) 磁気共鳴造影剤
JP6789991B2 (ja) 癌の早期骨転移の画像診断剤
JP2008528617A5 (https=)
JP2013507345A5 (https=)
JP2012520855A5 (https=)